translate English to French: Respondents were less likely to support exclusion of a leading expert who had a professional association with industry, a patient advocate who had used the drug under review, or a member of a patient group that received industry funding.
Elle exige la divulgation publique d’un sommaire de l’expertise ou de l’expérience, des intérêts et des affiliations d’une personne en tant que critère de nomination au sein d’un organisme consultatif.